Chief Innovation/Tech Officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), Schobel Alexander Mark, sells 23,460 shares worth $158,355
According to Aquestive Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 08:17 PM, company Chief Innovation/Tech Officer, Schobel Alexander Mark disclosed selling 23,460 shares at a cost of $6.75. At the time of this transaction (Feb 10), this trade was worth $158,355 in total. As of Feb 10, Schobel Alexander Mark now owns 837,000 shares in total worth about $5,633,010.0.
For the last few recent trades made by Aquestive Therapeutics, Inc. (NASDAQ:AQST) Chief Innovation/Tech Officer, Schobel Alexander Mark, we have the following information:
- SEC Form 4 filing: Feb 09: Sold 11,540 shares at the rate of $6.75 per share. Total worth of this trade was $77,895. Total number of shares owned as of Feb 09 were 860,460
- SEC Form 4 filing: Feb 08: Sold 40,792 shares at the rate of $6.50 per share. Total worth of this trade was $265,148. Total number of shares owned as of Feb 08 were 872,000
- SEC Form 4 filing: May 08: Sold 40,000 shares at the rate of $5.00 per share. Total worth of this trade was $200,000. Total number of shares owned as of May 08 were 902,113
Posted by
George Daniels
on Wednesday February 10 2021, 11:23 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
